Cannabis with high Δ9-THC contents affects perception and visual selective attention acutely: An event-related potential study

Pharmacology Biochemistry and Behavior

Volumn 96, Issue 1, 2010, Pages 67-74

  Bocker K B E ^a,b   Gerritsen, J ^a,b   Hunault, C C ^c   Kruidenier, M ^c   Mensinga, Tj T ^c   Kenemans, J L ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

9 Tetrahydrocannabinol (THC); (Acute) dose response relationship; (Selective) attention; Event Related Potentials (ERPs)

Indexed keywords

CANNABIS; DRONABINOL; PLACEBO;

ACCURACY; ADULT; ALCOHOL CONSUMPTION; ANIMAL BEHAVIOR; ARTICLE; BLOOD LEVEL; CANNABIS SMOKING; CIGARETTE SMOKING; CONTINGENT NEGATIVE VARIATION; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; EMPLOYMENT STATUS; EVENT RELATED POTENTIAL; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; MALE; NORMAL HUMAN; PERCEPTION; PRIORITY JOURNAL; REACTION TIME; SELECTIVE ATTENTION; TASK PERFORMANCE; VISUAL DISCRIMINATION; VISUAL STIMULATION; VOLUNTEER;

ADOLESCENT; ADULT; ATTENTION; CANNABIS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EVOKED POTENTIALS, VISUAL; HUMANS; MALE; MARIJUANA SMOKING; PHOTIC STIMULATION; PSYCHOMOTOR PERFORMANCE; REACTION TIME; TETRAHYDROCANNABINOL; TIME FACTORS; VISUAL PERCEPTION; YOUNG ADULT;

CANNABIS;

EID: 77953292288     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.04.008     Document Type: Article

References (66)

1. Ameri A. The effects of cannabinoids on the brain. Prog Neurobiol 1999, 58:315-348.
2. Amos A., Wiltshire S., Bostock Y., Haw S., McNeill A. 'You can't go without a fag... you need it for your hash' - a qualitative exploration of smoking, cannabis and young people. Addiction 2004, 99:77-81.
3. Bijl S., de Bruin E.A., Kenemans J.L., Verbaten M.N., Bocker K.B. Effects of chronic alcohol consumption in a visual attention task and an auditory oddball task: an event-related potential study. Alcohol Clin Exp Res 2005, 29:2029-2038.
4. Bötzel K., Ecker C., Schulze S. Topography and dipole analysis of reafferent electrical brain activity following the Bereitschaftspotential. Exp Brain Res 1997, 114:352-361.
5. Coles M.G.H., Gratton G., Donchin E. Detecting early communication: using measures of movement-related potentials to illuminate human information processing. Biol Psychol 1988, 26:69-89.
6. Curran H.V., Brignell C., Fletcher S., Middleton P., Henry J. Cognitive and subjective dose-response effects of acute oral Delta(9)-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology 2002, 164:61-70.
7. Donchin E. Presidential address, 1980. Surprise!...Surprise?. Psychophysiol 1981, 18:493-513.
8. D'Souza D.C., Perry E., MacDougall L., Ammerman Y., Cooper T., Wu Y.T., Braley G., Gueorguieva R., Krystal J.H. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 2004, 29:1558-1572.
9. D'Souza D.C., Ranganathan M., Braley G., Gueorguieva R., Zimolo Z., Cooper T., Perry E., Krystal J. Blunted psychotomimetic and amnestic effects of Delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology 2008, 33:2505-2516.
10. Eggan S.M., Lewis D.A. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex 2007, 17:175-191.
11. Ehrenreich H., Rinn T., Kunert H.J., Moeller M.R., Poser W., Schilling L., Gigerenzer G., Hoehe M.R. Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology 1999, 142:295-301.
12. El Sohly M.A. Quarterly report potency monitoring project # 85 2004, National Center for Natural Products Research, University of Mississippi.
13. Gratton G., Coles M.G., Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol 1983, 55:468-484.
14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 2003, 42:327-360.
15. Hart C.L., van Gorp W., Haney M., Foltin R.W., Fischman M.W. Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology 2001, 25:757-765.
16. Heinze H.J., Mangun G.R., Burchert W., Hinrichs H., Scholz M., Munte T.F., Gos A., Scherg M., Johannes S., Hundeshagen H. Combined spatial and temporal imaging of brain activity during visual selective attention in humans. Nature 1994, 372:543-546.
17. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 1990, 87:1932-1936.
18. Hooker W.D., Jones R.T. Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication. Psychopharmacology (Berl) 1987, 91:20-24.
19. Hunault C., Mensinga T., de Vries I., Kelholt-Dijkman H., Hoek J., Kruidenier M., Leenders M., Meulenbelt J. Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69mg THC. Psychopharmacology 2008, 201:171-181.
20. Hunault C.C., Mensinga T.T., Bocker K.B.E., Schipper C.M.A., Kruidenier M., Leenders M.E.C., de Vries I., Meulenbelt J. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69mg delta-9-tetrahydrocannabinol (THC). Psychopharmacology 2009, 204:85-94.
21. Ilan A.B., Smith M.E., Gevins A. Effects of marijuana on neurophysiological signals of working and episodic memory. Psychopharmacology 2004, 176:214-222.
22. Ilan A.B., Gevins A., Coleman M., ElSohly M.A., de Wit H. Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids. Behav Pharmacol 2005, 16:487-497.
23. Iversen L. Cannabis and the brain. Brain 2003, 126:1252-1270.
24. Juckel G., Roser P., Nadulski T., Stadelmann A.M., Gallinat J. Acute effects of Delta(9)-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity. Schizophr Res 2007, 97:109-117.
25. Justinova Z., Goldberg S.R., Heishman S.J., Tanda G. Self-administration of cannabinoids by experimental animals and human marijuana smokers. Pharmacol Biochem Behav 2005, 81:285-299.
26. Kempel P., Lampe K., Parnefjord R., Hennig J., Kunert H.J. Auditory-evoked potentials and selective attention: different ways of information processing in cannabis users and controls. Neuropsychobiology 2003, 48:95-101.
27. Kenemans J.L., Lorist M.M. Caffeine and selective visual processing. Pharmacol Biochem Behav 1995, 52:461-471.
28. Kenemans J.L., Kok A., Smulders F.T. Event-related potentials to conjunctions of spatial frequency and orientation as a function of stimulus parameters and response requirements. Electroencephalogr Clin Neurophysiol 1993, 88:51-63.
29. Kenemans J.L., Smulders F.T., Kok A. Selective processing of two-dimensional visual stimuli in young and old subjects: electrophysiological analysis. Psychophysiol 1995, 32:108-120.
30. Kenemans J.L., Baas J.M.P., Mangun G.R., Lijffijt M., Verbaten M.N. On the processing of spatial frequencies as revealed by evoked-potential source modeling. Clin Neurophysiol 2000, 111:1113-1123.
31. Kenemans J.L., Lijffijt M., Camfferman G., Verbaten M.N. Split-second sequential selective activation in human secondary visual cortex. J Cogn Neurosc 2002, 14:48-61.
32. Koethe D., Gerth C.W., Neatby M.A., Haensel A., Thies M., Schneider U., Emrich H.M., Klosterkotter J., Schultze-Lutter F., Leweke F.M. Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness. Schizophr Res 2006, 88:142-150.
33. Kok A. On the utility of P3 amplitude as a measure of processing capacity. Psychophysiol 2001, 38:557-577.
34. Kristeva-Feige R., Rossi S., Feige B., Mergner T., Lucking C.H., Rossini P.M. The bereitschaftspotential paradigm in investigating voluntary movement organization in humans using magnetoencephalography (MEG). Brain Res Protoc 1997, 1:13-22.
35. Leweke F.M., Schneider U., Thies M., Munte T.F., Emrich H.M. Effects of synthetic Delta(9)-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man. Psychopharmacology 1999, 142:230-235.
36. Leweke F.M., Schneider U., Radwan M., Schmidt E., Emrich H.M. Different effects of nabilone and cannabidiol on binocular depth inversion in man. Pharmacol Biochem Behav 2000, 66:175-181.
37. Lichtman A.H., Varvel S.A., Martin B.R. Endocannabinoids in cognition and dependence. Prostaglandins Leukot Essent Fatty Acids 2002, 66:269-285.
38. Lundqvist T. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav 2005, 81:319-330.
39. Mangun G. Neural mechanisms of visual selective attention. Psychophysiol 1995, 32:4-18.
40. Miller J., Patterson T., Ulrich R. Jackknife-based method for measuring LRP onset latency differences. Psychophysiology 1998, 35:99-115.
41. Mordkoff J.T., Gianaros P.J. Detecting the onset of the lateralized readiness potential: a comparison of available methods and procedures. Psychophysiology 2000, 37:349-360.
42. Niesink R.J.M., Rigter S., Hoek J. THC-concentraties in wiet, nederwiet en hash in Nederlandse coffeshops, 2003-2004 [THC concentrations in cannabis, home-grown cannabis and hashish in Dutch coffeeshops, 2003-2004] 2004, Trimbos Institute, Utrecht, The Netherlands.
43. Nordstrom B.R., Hart C.L. Assessing cognitive functioning in cannabis users: cannabis use history an important consideration. Neuropsychopharmacology 2006, 31:2798-2799.
44. O'Leary D.S., Block R.I., Koeppel J.A., Flaum M., Schultz S.K., Andreasen N.C., Ponto L.B., Watkins G.L., Hurtig R.R., Hichwa R.D. Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology 2002, 26:802-816.
45. Patrick C.J., Berthot B.D. Startle potentiation during anticipation of a noxious stimulus: active versus passive response sets. Psychophysiol 1995, 32:72-80.
46. Patrick G., Straumanis J.J., Struve F.A., Nixon F., Fitzgerald M.J., Manno J.E., Soucair M. Auditory and visual P300 event-related potentials are not altered in medically and psychiatrically normal chronic marijuana users. Life Sci 1995, 56:2135-2140.
47. Patrick G., Straumanis J.J., Struve F.A., Fitzgerald M.J., Manno J.E. Early and middle latency evoked potentials in medically and psychiatrically normal daily marihuana users: a paucity of significant findings. Clin Electroencephalogr 1997, 28:26-31.
48. Polich J. Updating p300: an integrative theory of P3a and P3b. Clin Neurophysiol 2007, 118:2128-2148.
49. Polich J., Criado J.R. Neuropsychology and neuropharmacology of P3a and P3b. Int J Psychophysiol 2006, 60:172-185.
50. Polich J., Herbst K.L. P300 as a clinical assay: rationale, evaluation, and findings. Int J Psychophysiol 2000, 38:3-19.
51. Pope H.G., Gruber A.J., Yurgelun-Todd D. The residual neuropsychological effects of cannabis - the current status of research. Drug Alcohol Depend 1995, 38:25-34.
52. Pope H.G., Gruber A.J., Hudson J.I., Huestis M.A., Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 2001, 58:909-915.
53. Pope H.G., Gruber A.J., Hudson J.I., Cohane G., Huestis M.A., Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association?. Drug Alcohol Depend 2003, 69:303-310.
54. Potter D.J., Clark P., Brown M.B. Potency of Delta(9)-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology. J Forensic Sci 2008, 53:90-94.
55. Pritchard W., Sokhadze E., Houlihan M. Effects of nicotine and smoking on event-related potentials: a review. Nicotin Tob Res 2004, 6:961-984.
56. Ramaekers J.G., Berghaus G., van Laar M., Drummer O.H. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend 2004, 73:109-119.
57. Ramaekers J.G., Kauert G., van Ruitenbeek P., Theunissen E.L., Schneider E., Moeller M.R. High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology 2006, 31:2296-2303.
58. Ranganathan M., D'Souza D.C. The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology 2006, 188:425-444.
59. Roser P., Juckel G., Rentzsch J., Nadulski T., Gallinat J., Stadelmann A.M. Effects of acute oral Delta(9)-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers. Eur Neuropsychopharmacol 2008, 18:569-577.
60. Shibasaki H., Barrett G., Halliday E., Halliday A.M. Cortical potentials following voluntary and passive finger movements. Electroencephalogr Clin Neurophysiol 1980, 50:201-213.
61. Skosnik P.D., Krishnan G.P., Vohs J.L., O'Donnell B.F. The effect of cannabis use and gender on the visual steady state evoked potential. Clin Neurophysiol 2006, 117:144-156.
62. Solowij N., Michie P.T., Fox A.M. Effects of long-term cannabis use on selective attention - an event-related potential study. Pharmacol Biochem Behav 1991, 40:683-688.
63. Solowij N., Michie P.T., Fox A.M. Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiatry 1995, 37:731-739.
64. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410:588-592.
65. Yoon H.H., Iacono W.G., Malone S.M., McGue M. Using the brain P300 response to identify novel phenotypes reflecting genetic vulnerability for adolescent substance misuse. Addict Behav 2006, 31:1067-1087.
66. Zuurman L., Roy C., Schoemaker R.C., Hazekamp A., den Hartigh J., Bender J.C.M.E., Verpoorte R., Pinquier J.L., Cohen A.F., van Gerven J.M.A. Effect of intrapulmonary tetrahydrocannabinol administration in humans. J Psychopharmacol 2008, 22:707-716.